Frequently Asked Questions
The major factor is the rising demand for the Silicone Nasal Cannula market due to the increasing prevalence of respiratory diseases such as asthma and COPD. The increasing smoking rate will contribute to the growing adoption of COPD, which is expected to boost the silicone nasal cannula market. The increasing demand for nasal cannulas is the growing number of manufacturers and suppliers across the globe. Additionally, the development of nasal cannulas such as silicone materials, extra soft, curved
The global silicone nasal cannula market is anticipated to grow at a substantial CAGR of 5.90% in the upcoming years. The global silicone nasal cannula market was estimated to be worth USD 729.5 million in 2021 and was expected to be worth USD 1,028.96 million by 2028.
In 2021, North America dominated the highest market share in the global silicone nasal cannula market due to the increasing prevalence of respiratory diseases such as COPD and asthma, driving the silicone nasal cannula market in North America. Furthermore, with the increasing number of local and international manufacturing facilities, the product is available at the lowest cost and the growing adoption is expected in the silicone nasal cannula market in the North American region. Additionally, the
The main competitors dominating the global silicone nasal cannulas market include Allied Healthcare Products, Inc., Teleflex Incorporated, Flexicare Medical Ltd., Vapotherm Inc., ResMed Inc., Fairmont Medical, Fisher & Paykel Healthcare Limited, Well Lead Medical Co. Ltd., and Salter Labs.
In 2021, the Hospitals segment dominated and accounted for the largest silicone nasal cannula market share. Due to the increasing adoption of high-flow nasal cannulas, critical respiratory distress needs high-flow oxygen.